GeneChem is a leading manager of specialized biotechnology venture capital funds. With over $350 million in assets distributed over four funds, including GeneChem Technologies, GeneChem Therapeutics, AgeChem, and AmorChem, we are dedicated to investing in companies involved in drug discovery and development. Since 1997, we have successfully invested in over 60 companies located in the US, Canada, and Europe.

At GeneChem, we believe that successful deals combine innovative science, insightful management, and collaborative investor syndicate. Our team is passionate about identifying and supporting promising biotech ventures, ensuring the growth and success of the companies we invest in. Located at 1 Westmount Square, Suite 800, Montreal, Quebec, H3Z 2P9, Canada, we are committed to making a positive impact in the biotechnology industry.

Contact us at T 514-849-7696 or info@genechem. com to learn more about how we can help your biotech company thrive